foxo4-dri senolytic peptide human trial The disordered p53 transactivation domain is the target of FOXO4 and the compound TCG_21761 b12 self injection pen Package size:3 Bottles
SKU: 92274331128
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 18 - Sep 23